3RCW
Crystal Structure of the bromodomain of human BRD1
3RCW の概要
| エントリーDOI | 10.2210/pdb3rcw/pdb |
| 分子名称 | Bromodomain-containing protein 1, 1-methylpyrrolidin-2-one, ACETATE ION, ... (5 entities in total) |
| 機能のキーワード | transcription, bromodomain, structural genomics, structural genomics consortium, sgc |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Nucleus : O95696 |
| タンパク質・核酸の鎖数 | 8 |
| 化学式量合計 | 125644.91 |
| 構造登録者 | Filippakopoulos, P.,Keates, T.,Picaud, S.,Felletar, I.,Pike, A.C.W.,Krojer, T.,von Delft, F.,Arrowsmith, C.H.,Edwards, A.M.,Weigelt, J.,Bountra, C.,Knapp, S.,Structural Genomics Consortium (SGC) (登録日: 2011-03-31, 公開日: 2011-06-01, 最終更新日: 2023-09-13) |
| 主引用文献 | Filippakopoulos, P.,Picaud, S.,Mangos, M.,Keates, T.,Lambert, J.P.,Barsyte-Lovejoy, D.,Felletar, I.,Volkmer, R.,Muller, S.,Pawson, T.,Gingras, A.C.,Arrowsmith, C.H.,Knapp, S. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell(Cambridge,Mass.), 149:214-231, 2012 Cited by PubMed Abstract: Bromodomains (BRDs) are protein interaction modules that specifically recognize ε-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all BRD families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family. PubMed: 22464331DOI: 10.1016/j.cell.2012.02.013 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.21 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






